Filter
785
Filtered Results: 785
Text search:
drug
or
vaccine
reaction
Featured
Recommendations
96
New Publications
223
Language
Document type
No document type
436
Guidelines
143
Studies & Reports
97
Manuals
41
Strategic & Response Plan
30
Fact sheets
15
Training Material
12
Situation Updates
5
Brochures
3
Infographics
2
Resource Platforms
1
Countries / Regions
India
41
Kenya
27
South Africa
25
Nigeria
22
Global
21
Uganda
21
Ethiopia
21
Western and Central Europe
20
Tanzania
18
Ghana
17
Nepal
15
Latin America and the Carribbean
14
Africa
11
Zambia
11
Sierra Leone
10
Malawi
10
Liberia
10
Bangladesh
9
Namibia
9
Myanmar / Burma
9
Rwanda
8
Zimbabwe
8
Eastern Europe
8
Lesotho
6
Senegal
6
Philippines
6
South–East Asia Region
6
Congo, Democratic Republic of
5
Germany
4
Botswana
4
Burkina Faso
3
USA
3
Cambodia
3
West and Central Africa
3
Western Pacific Region
3
Brazil
3
Ukraine
2
Cameroon
2
Haiti
2
Venezuela
2
Middle East and North Africa
2
Eastern Europe and Central Asia
2
East and Southern Africa
2
South Sudan
2
Indonesia
2
Thailand
1
Mexico
1
Turkey
1
Gambia
1
Syria
1
Iran
1
Mozambique
1
Asia
1
Argentina
1
Lebanon
1
Papua New Guinea
1
Russia
1
Central African Republic
1
Angola
1
Somalia
1
Solomon Islands
1
Eswatini/ Swaziland
1
Pakistan
1
Authors & Publishers
Publication Years
Category
Countries
319
Clinical Guidelines
116
Public Health
34
Women & Child Health
28
Key Resources
19
Pharmacy & Technologies
17
Capacity Building
12
Toolboxes
TB
84
COVID-19
66
HIV
53
Pharmacy
46
NTDs
43
Rapid Response
42
Ebola & Marburg
31
AMR
31
Caregiver
17
Refugee
15
Mental Health
12
Conflict
10
Natural Hazards
7
Cholera
7
Polio
7
NCDs
6
Zika
6
Planetary Health
5
Specific Hazards
4
Health Financing Toolbox
4
Global Health Education
3
Disability
1
Saudi Journal of Biological Sciences. http://dx.doi.org/10.1016/j.sjbs.2016.03.006
Open Access
Pharmaceutical regulators are at the forefront of ensuring that only safe and effective medicines are authorized and available in the market. This document builds on the recommendations in the above publication and has been prepared to specifically assist national medicines regulatory authorities to...
Interagency Guidelines - This revised Interagency List of Essential Medicines for Reproductive Health presents
the current international consensus on rational selection of essential reproductive health medicines. The list is intended to support decisions regarding the production, quality assurance...
Draft for consultation
Version 2, January 2016
The primary purpose of this document is to provide 3MDG stakeholders with some essential information on the MNCH core-indicators for 3MDG, which were derived from the 3MDG Logical Framework, Data Dictionary for Health Service Indicators (2014 June, DoPH, MoH), A ... (MEASURE Evaluation, September 2005) and Monitoring Emergency Obstetric Care (WHO/UNICEF/UNFPA/AMDD). Partners are strongly encouraged to integrate the MNCH indicators into their ongoing monitoring and evaluation (M&E) activities.
These indicators are designed to help Partners assess the current state of their activities, their progress towards achieving their targets, and contribution towards the national response. This guideline is designed to improve the quality and consistency of data collected at the township level, which will enhance the accuracy of conclusions drawn when the data are aggregated.
The primary purpose of this document is to provide 3MDG stakeholders with some essential information on the MNCH core-indicators for 3MDG, which were derived from the 3MDG Logical Framework, Data Dictionary for Health Service Indicators (2014 June, DoPH, MoH), A ... (MEASURE Evaluation, September 2005) and Monitoring Emergency Obstetric Care (WHO/UNICEF/UNFPA/AMDD). Partners are strongly encouraged to integrate the MNCH indicators into their ongoing monitoring and evaluation (M&E) activities.
These indicators are designed to help Partners assess the current state of their activities, their progress towards achieving their targets, and contribution towards the national response. This guideline is designed to improve the quality and consistency of data collected at the township level, which will enhance the accuracy of conclusions drawn when the data are aggregated.
In the context of the coronavirus disease (COVID-19) pandemic response, WHO identifies young people as a priority target audience with specific concerns, experiences and behaviours. This policy brief provides relevant insights from behavioural evidence and a set of behavioural considerations for tho...
Dermatological Preparations For The Tropics
recommended
A formulary of dermatological preparations and background information on therapeutic choices, production and dispensing. 2nd edition
Blue Book. The Medical Guide for our Projects
recommended
9th edition; 4th English edition 2020
English version - This handbook sets out a the new paradigm for pharmacy practice. Its aim is to guide pharmacy educators in pharmacy practice, to educate pharmacy students and to guide pharmacists in practice to update their skills. The handbook, which brings together practical tools and knowledge,...
The document provides detailed guidelines for the production, formulation, and implementation of oral rehydration salts (ORS) to combat dehydration caused by diarrhoea, particularly in children. It focuses on the composition, quality standards, and packaging requirements of ORS, aiming to support na...
The purpose of this guidance is to assist WHO Member States, and other stakeholders, in the establishment and development of programmes of integrated surveillance of antimicrobial resistance in foodborne bacteria (i.e., bacteria commonly transmitted by food). In this guidance, “integrated surveill...
This Tuberculosis guide has been developed jointly by Médecins Sans Frontières and Partners In Health. It aims at providing useful information to the clinicians and health staff for the comprehensive management of tuberculosis. Forms of susceptible and resistant tuberculosis, tuberculosis in child...
Application of a One Health approach .
The present guidance was developed with the support of the WHO Advisory Group on Integrated Surveillance of Antimicrobial Resistance (AGISAR) to assist countries and other stakeholders in the establishment and development of programmes of integrated surveillan...
Therapeutics for Ebola virus disease
recommended
The WHO Ebola Virus Disease (EVD) Clinical management: living guidance contains the Organization’s most up-to-date recommendations for the clinical management of people with EVD. Providing guidance that is comprehensive and holistic for the optimal care of patients with EVD throughout their il...
Antimicrobial agents play an indispensable role in animal health and welfare management. At the same time, the need for prudent use is obvious to ensure good food safety outcomes and to manage the potential risk of antimicrobial resistance. The emergence of multi-resistant bacteria is posing challen...
